Skip to content

Transthoracic Sonography Versus High Resolution Computed Tomography in Alveolar Intersitial Syndrome

Can High Frequency Transthoracic Sonography Play a Competition Role With High Resolution Computed Tomography in Assessment of Alveolar Intersitial Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03172585
Enrollment
1
Registered
2017-06-01
Start date
2017-06-30
Completion date
2018-08-31
Last updated
2017-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Diseases

Brief summary

High resolution computed tomography of the chest is the gold standard imaging modality for most pulmonary diseases. However, the associated high expenses, radiation exposure , and its limited possibility for bedside use are a limitation.

Detailed description

High resolution computed tomography of the chest is the gold standard imaging modality for most pulmonary diseases. However, the associated high expenses, radiation exposure , and its limited possibility for bedside use are a limitation. Transthoracic ultrasonograghy is used progressively for evaluation of pulmonary diseases. Its non invasive nature , relatively low price ,portability for bedside use, and high reproducibility of results allows for incorporation of imaging findings with clinical data. Although Transthoracic ultrasonograghy is not an alternative to High resolution computed tomography,it can potentially provide useful supplemental information in certain specific situations ,such as for rapid bedside diagnostic assessment of dyspneic patients. B-line is a common and significant abnormal sign used for diagnostic appraisal by Transthoracic ultrasonograghy, but it cannot define the exact underlying pathologic feature on a lung ultrasound. When the lung parenchymal pathology reaches the lung surface ,certain characteristic changes of the pleural line can be detected by means of the good imaging made possible by high-resolution Transthoracic ultrasonograghy ,but the application and strength of pleural line abnormalities in the differential diagnosis of lung diseases has not been adequately explored . Existing literature on the illustration of the pleural line is scarce ,and the shape of pleural line has not been adequately investigated and described ,especially in comparison with Computed tomography findings. Most studies that have investigated pleural lines are confined to the sub population with interstitial lung diseases.

Interventions

High resolution computed tomography of the chest is the gold standard imaging modality for most pulmonary diseases

OTHERtrans thoracic ultrasonography

Trans thoracic ultrasonograghy is used progressively for evaluation of pulmonary diseases . Its non invasive nature , relatively low price ,portability for bedside use, and high reproducible of results allows for incorporation of imaging findings with clinical data

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients presenting with dyspnea due to interstitial fibrosis syndrome. 2. pulmonary edema due to any cause.

Exclusion criteria

1. Traumatic lesions 2. Pneumothorax 3. Subcutaneous emphysema 4. Massive pleural effusion with atelectasis, and

Design outcomes

Primary

MeasureTime frameDescription
the number of patients diagnosed with pleural diseases by high resolution computed tomography30 minutescomputed tomography on the chest

Contacts

Primary ContactGamal Rabeea, MD
gamalagmy135@gmail.com00201221729476
Backup ContactMohamed Fawzy, MD
mohamedadam200010@yahoo.com00201003032335

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026